查詢結果分析
相關文獻
- 肝癌治療核醫藥物[仦I/[fef3]]Iododeoxyuridine 之合成與配方研究
- 臺灣放射醫學科技研發與應用之現況與展望
- 核能研究所同位素及輻射的民生應用簡介
- The Research / Development and Medical Applications of Isotope and Radiation Technology in Taiwan
- 類神經網路模型應用於超音波換能器與組織參數之估測
- Radiosynthesis of 6-[洤F]Fluoro-L-FDOPA for Dopaminergic Function Imaging with PET
- 臨床核醫藥物之最新發展
- 鎝同位素及配位化合物在核子醫學上之發展與應用
- 放射核種的治療應用評論
- 同位素與核醫藥物研發與應用專輯序言
頁籤選單縮合
題 名 | 肝癌治療核醫藥物[仦I/[fef3]]Iododeoxyuridine 之合成與配方研究=The Preparation and Formulation Study on [仦I/[fef3]]Iododeoxyuridine Radiopharmaceutical for Hepatoma Therapy |
---|---|
作 者 | 王信二; 季匡華; 顏上惠; 陳富都; 周衛樂; 黃廣良; 魏孝萍; 丁幹; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 5:4 1998.12[民87.12] |
頁 次 | 頁285-291 |
分類號 | 416.36 |
關鍵詞 | 核醫藥物; 腫瘤治療; Radiopharmaceutical; Cancer therapy; 5-iodo-2'-deoxyuridine; Lipiodol; |
語 文 | 中文(Chinese) |
中文摘要 | 目的:肝癌是目前臺灣男性惡性腫瘤死亡率最高的癌症,本文敘述肝癌放射治療藥 物 [ �哈� ]UdR 之治療機制、製備方法及安定性分析。 材料與方法:本研究以自行合成之 5-tributylstannyl-2'-deoxyuridine (Bu �� SnUdR) 為前驅物進行放射性碘標幟,反應完 成後加入適量 gentisic acid,再經冷凍濃縮純化即得到 [ �哈� / �鞷� ]UdR 凍晶小瓶成 品。 結果: 自製之 [ �哈� / �鞷� ]UdR 凍晶小瓶, 於使用前加入適量生理食鹽水或 lipiodol 溶液配成所需之放射活性濃度,即可供肝癌或其他惡性腫瘤治療研究之用。 二種 配方之溶液放射化學純度均可達 97% 以上。 本研究進行一系列之 [ �哈� / �鞷� ]UdR 安 定性試驗, 結果顯示添加 gentisic acid 對 [ �哈� / �鞷� ]UdR 溶液或凍晶成品均可明 顯增加其貯存安定性, 而凍晶成品之安定性遠優於溶液成品。 結論:本研究製備完成之 [ �哈� / �鞷� ]UdR 核醫藥物,放射化學純度高且安定性佳, 可提供國人進行肝癌或其他惡 性腫瘤治療研究之用。 |
英文摘要 | Purpose:Hepatoma is one of the most prevalent male cancers in Taiwan. This paper investigates the interaction mechanism, preparation, formulation and stability of 5-[ �哈� / �鞷� ]-iodo-2'-deoxyuridine as a potential radiopharmaceutical for hepatoma and cancers treatment. Materials and Methods:The self-synthesized 5-tributylstanny-2'-deoxyuridine (Bu �� SnUdR), used as a precursor, was radioiodinated to produced [ �哈� / �鞷� ]IUdR. After adding the stabilizer, gentisic acid, the resultant reaction mixture was dispensed and lyophilized to give the [ �哈� / �鞷� ]IUdR hot kits. Results:The lyophilized [ �哈� / �鞷� ]IUdR hot kit was added with an appropriate amount of normal saline or lipiodol prior to preclinical hepatoma treatment studies. The radiochemical purity for the studied formulation was higher than 97%. When gentisic acid was used as a stabilizer, the stability of [ �哈� / �鞷� ]IUdR was significantly increased, and the stability of lyophilized form is far better than that of solution form. Conclusion:A stable radiopharmaceutical [ �哈� / �� Ⅰ ]IUdR with high radiochemical purity and specific activity was prepared in this study. Its use for preclinical and clinical studies on hepatoma and cancers therapy will be carried out in the further investigation. |
本系統中英文摘要資訊取自各篇刊載內容。